Drug Shortage Report for CEFUROXIME FOR INJECTION, USP
| Report ID | 122222 |
| Drug Identification Number | 02422301 |
| Brand name | CEFUROXIME FOR INJECTION, USP |
| Common or Proper name | CEFUROXIME FOR INJECTION, USP |
| Company Name | HIKMA CANADA LIMITED |
| Market Status | DORMANT |
| Active Ingredient(s) | CEFUROXIME |
| Strength(s) | 1.5G |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 25 VIALS |
| ATC code | J01DC |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2020-03-31 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2020-08-13 |
| Company comments | BUSINESS REASONS |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 5995 AVEBURY ROAD, SUITE 804 MISSISSAUGA, ONTARIO CANADA L5R 3P9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2020-08-13 | French | Compare |
| v1 | 2020-08-13 | English | Compare |
Showing 1 to 2 of 2